Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D007918:Leprosy / Q000150:complications / Q000188:drug therapy*; D008528:Mefenamic Acid / Q000627:therapeutic use; D008696:Methandrostenolone / Q000627:therapeutic use*; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D003907:Dexamethasone; D003622:Dapsone; D008696:Methandrostenolone